Aptorum Group (APM) Competitors $1.29 -0.11 (-7.86%) Closing price 03:59 PM EasternExtended Trading$1.31 +0.02 (+1.55%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock APM vs. PHGE, SNYR, ESLA, DYAI, RANI, SLGL, BDRX, KZR, ENLV, and OKURShould you be buying Aptorum Group stock or one of its competitors? The main competitors of Aptorum Group include BiomX (PHGE), Synergy CHC (SNYR), Estrella Immunopharma (ESLA), Dyadic International (DYAI), Rani Therapeutics (RANI), Sol-Gel Technologies (SLGL), Biodexa Pharmaceuticals (BDRX), Kezar Life Sciences (KZR), Enlivex Therapeutics (ENLV), and OnKure Therapeutics (OKUR). These companies are all part of the "pharmaceutical products" industry. Aptorum Group vs. Its Competitors BiomX Synergy CHC Estrella Immunopharma Dyadic International Rani Therapeutics Sol-Gel Technologies Biodexa Pharmaceuticals Kezar Life Sciences Enlivex Therapeutics OnKure Therapeutics BiomX (NYSEMKT:PHGE) and Aptorum Group (NASDAQ:APM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability. Do analysts rate PHGE or APM? BiomX presently has a consensus price target of $21.00, suggesting a potential upside of 3,656.71%. Given BiomX's stronger consensus rating and higher probable upside, equities analysts plainly believe BiomX is more favorable than Aptorum Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BiomX 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Aptorum Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in PHGE or APM? 40.6% of BiomX shares are held by institutional investors. Comparatively, 3.8% of Aptorum Group shares are held by institutional investors. 1.2% of BiomX shares are held by insiders. Comparatively, 64.0% of Aptorum Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is PHGE or APM more profitable? Aptorum Group's return on equity of 0.00% beat BiomX's return on equity.Company Net Margins Return on Equity Return on Assets BiomXN/A -127.82% -56.50% Aptorum Group N/A N/A N/A Does the media prefer PHGE or APM? In the previous week, Aptorum Group had 1 more articles in the media than BiomX. MarketBeat recorded 2 mentions for Aptorum Group and 1 mentions for BiomX. BiomX's average media sentiment score of 0.00 beat Aptorum Group's score of -0.23 indicating that BiomX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BiomX 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aptorum Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, PHGE or APM? BiomX has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, Aptorum Group has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500. Which has stronger earnings and valuation, PHGE or APM? Aptorum Group has higher revenue and earnings than BiomX. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiomXN/AN/A-$28.32M-$0.85-0.66Aptorum Group$430K16.05-$4.27MN/AN/A SummaryBiomX and Aptorum Group tied by winning 6 of the 12 factors compared between the two stocks. Get Aptorum Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APM vs. The Competition Export to ExcelMetricAptorum GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.49M$2.52B$5.57B$9.48BDividend YieldN/A1.77%4.31%4.14%P/E RatioN/A19.5129.3423.98Price / Sales16.05691.08442.0695.84Price / CashN/A162.3535.8458.51Price / Book0.595.208.085.58Net Income-$4.27M$31.61M$3.26B$265.35M7 Day Performance-22.29%-0.96%-0.73%-0.89%1 Month Performance34.38%5.16%5.52%4.98%1 Year Performance-55.67%3.25%28.79%23.50% Aptorum Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APMAptorum Group1.2869 of 5 stars$1.29-7.9%N/A-52.4%$7.49M$430K0.0030News CoverageGap DownPHGEBiomX2.047 of 5 stars$0.42-43.6%$21.00+4,936.0%-76.4%$11.24MN/A-0.57120News CoverageSNYRSynergy CHC4.0009 of 5 stars$3.66-1.6%$10.00+173.2%+11,833.3%$33.64M$34.83M0.0040News CoverageESLAEstrella Immunopharma2.389 of 5 stars$0.93+1.0%$16.00+1,622.3%-40.5%$33.60MN/A-3.57N/ADYAIDyadic International3.2731 of 5 stars$1.12+0.9%$6.00+435.7%-26.3%$33.55M$3.49M-5.577News CoverageUpcoming EarningsGap UpRANIRani Therapeutics1.9117 of 5 stars$0.52-6.5%$7.33+1,323.9%-77.6%$32.55M$1.03M-0.52110Negative NewsShort Interest ↑SLGLSol-Gel Technologies1.8254 of 5 stars$11.41-5.0%$40.00+250.6%+266.1%$31.83M$11.54M-2.4350Gap DownBDRXBiodexa Pharmaceuticals0.0827 of 5 stars$0.87-0.9%N/AN/A$31.83MN/A0.0020News CoverageShort Interest ↑KZRKezar Life Sciences3.5195 of 5 stars$4.31-1.3%$39.50+817.5%-30.4%$31.47M$7M-0.4060Negative NewsUpcoming EarningsShort Interest ↑ENLVEnlivex Therapeutics2.4597 of 5 stars$1.32+4.7%$10.00+658.2%+13.0%$31.20MN/A-2.0070Short Interest ↑Gap UpHigh Trading VolumeOKUROnKure Therapeutics2.5713 of 5 stars$2.32+1.7%$32.33+1,294.3%N/A$31.07MN/A-0.44N/AUpcoming Earnings Related Companies and Tools Related Companies PHGE Competitors SNYR Competitors ESLA Competitors DYAI Competitors RANI Competitors SLGL Competitors BDRX Competitors KZR Competitors ENLV Competitors OKUR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APM) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredInstant Cash (every 3rd Monday)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptorum Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptorum Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APM Stock Alerts